Ben Dickstein
About Ben Dickstein
Ben Dickstein is a Sr. Associate Scientist in Formulations at Lyndra Therapeutics, where he has worked since 2021. He has a background in Biomedical Engineering from Cornell University and has held various internships and research positions at notable organizations including Biogen, Moderna Therapeutics, and Tufts University.
Work at Lyndra Therapeutics
Ben Dickstein currently serves as a Senior Associate Scientist in Formulations at Lyndra Therapeutics. He has held this position since 2021, contributing to the development of innovative drug delivery systems. Prior to this role, he worked as a Formulations Co-Op at the same organization from 2020 to 2021. His experience at Lyndra Therapeutics involves applying his expertise in biomedical engineering to enhance formulation strategies.
Education and Expertise
Ben Dickstein earned a Bachelor of Science in Biomedical Engineering from Cornell University, completing his studies from 2016 to 2020. He further advanced his education by obtaining a Master of Engineering in Biomedical Engineering from Cornell University, which he completed in 2021. His academic background provides a strong foundation for his work in formulations and drug delivery systems.
Background
Ben Dickstein's professional journey includes various internships and research roles. He began his career as an Engineering Intern at Allurion Technologies in 2015. He then gained experience as a Biomolecular Engineering Research Intern at Tufts University in 2017. His research experience continued at Cornell University, where he worked as an Undergraduate Researcher in the Wang Lab from 2018 to 2019 and as a Graduate Researcher in the Putnam Group from 2020 to 2021.
Previous Work Experience
Before his current role at Lyndra Therapeutics, Ben Dickstein held several internships. He worked as an Antisense Oligonucleotide Intern at Biogen for three months in 2019 and as a Graduate Software Engineer Intern at MITRE for one month in 2020. Additionally, he interned at Moderna Therapeutics as a Formulations Intern for two months in 2018. These experiences have contributed to his expertise in the field of biomedical engineering.